Lane Labs USA

House Government Reform Committee Chairman Dan Burton (R-Ind.) questions FDA's actions against Lane's BeneFin, SkinAnswer and MGN-3 products in a March 27 letter. The agency, in a Dec. 8 complaint filed in Newark, N.J. federal court, is seeking a permanent injunction against the sale of the products, stating they are "unapproved drugs" (1"The Tan Sheet" Dec. 20, 1999, p. 5). Burton notes Lane Labs is testing BeneFin's anti-cancer effects under an IND application, but if "each manufacturer is going to be sued by the FDA for conducting research, then a disincentive has been created." Saying he has received over 300 letters from consumers in support of Lane Labs, the Indiana Republican advises FDA to "create a category of research application specifically tailored to dietary supplements so that research is encouraged...and companies are not at risk for legal action"